| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yuxin Yi, Shixing Wu, Maosheng Ye, Yi Zeng, Ping Zhang, Yiqun Xi. [Effect of Aβ1-42 injection on hippocampus cells in rats and protective role of polygona-polysaccharose for Alzheimer's disease]. Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences. vol 39. issue 4. 2015-09-08. PMID:24820272. |
[effect of aβ1-42 injection on hippocampus cells in rats and protective role of polygona-polysaccharose for alzheimer's disease]. |
2015-09-08 |
2023-08-13 |
rat |
| Edward D Levin, Brandon J Hall, Amir H Rezvan. Heterogeneity across brain regions and neurotransmitter interactions with nicotinic effects on memory function. Current topics in behavioral neurosciences. vol 23. 2015-09-08. PMID:25655888. |
alzheimer's disease results in a dramatic decrease in hippocampal nicotinic receptor density, affecting α4β2 receptor expression most prominently. |
2015-09-08 |
2023-08-13 |
rat |
| Ashok K Shett. Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection? Epilepsy & behavior : E&B. vol 38. 2015-09-03. PMID:24433836. |
damage to the hippocampus can occur through many causes including head trauma, ischemia, stroke, status epilepticus, and alzheimer's disease. |
2015-09-03 |
2023-08-12 |
Not clear |
| Ashok K Shett. Hippocampal injury-induced cognitive and mood dysfunction, altered neurogenesis, and epilepsy: can early neural stem cell grafting intervention provide protection? Epilepsy & behavior : E&B. vol 38. 2015-09-03. PMID:24433836. |
this review presents advancements made in nsc grafting therapy for treating hippocampal injury in animal models of excitotoxic injury, traumatic brain injury, alzheimer's disease, and status epilepticus; potential mechanisms of functional recovery mediated by nsc grafts placed early after hippocampal injury; and issues that need to be resolved prior to considering clinical application of nsc grafting for hippocampal injury. |
2015-09-03 |
2023-08-12 |
Not clear |
| Marjan Shariatpanahi, Fariba Khodagholi, Ghorbangol Ashabi, Azar Aghazadeh Khasraghi, Leila Azimi, Mohammad Abdollahi, Mohammad Hossein Ghahremani, Seyed Nasser Ostad, Farshid Noorbakhsh, Mohammad Sharifzade. Ameliorating of Memory Impairment and Apoptosis in Amyloid β-Injected Rats Via Inhibition of Nitric Oxide Synthase: Possible Participation of Autophagy. Iranian journal of pharmaceutical research : IJPR. vol 14. issue 3. 2015-09-02. PMID:26330869. |
it has been proposed that appearance of amyloid beta (aβ) in hippocampus is one of the characteristic features of alzheimer's disease (ad). |
2015-09-02 |
2023-08-13 |
rat |
| Ephraim F Trakhtenberg, Melina I Morkin, Karan H Patel, Stephanie G Fernandez, Alan Sang, Peter Shaw, Xiongfei Liu, Yan Wang, Gregory M Mlacker, Han Gao, Dmitry Velmeshev, Susan M Dombrowski, Michael P Vitek, Jeffrey L Goldber. The N-terminal Set-β Protein Isoform Induces Neuronal Death. The Journal of biological chemistry. vol 290. issue 21. 2015-09-01. PMID:25833944. |
the expression and subcellular localization of set-β are altered in alzheimer disease, cleavage of set-β leads to neuronal death after stroke, and the full-length set-β regulates retinal ganglion cell (rgc) and hippocampal neuron axon growth and regeneration in a subcellular localization-dependent manner. |
2015-09-01 |
2023-08-13 |
Not clear |
| Naoya Aoki, Melissa E Murray, Kotaro Ogaki, Shinsuke Fujioka, Nicola J Rutherford, Rosa Rademakers, Owen A Ross, Dennis W Dickso. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A. Acta neuropathologica. vol 129. issue 1. 2015-08-31. PMID:25367383. |
hippocampal sclerosis in lewy body disease is a tdp-43 proteinopathy similar to ftld-tdp type a. hippocampal sclerosis (hpscl) is frequent in frontotemporal lobar degeneration with tdp-43 pathology (ftld-tdp), but it also occurs in dementia of the elderly with or without accompanying alzheimer type pathology. |
2015-08-31 |
2023-08-13 |
Not clear |
| Dan Wang, Zhao-Hui Guo, Xing-Han Liu, Yue-Hua Li, He Wan. Examination of hippocampal differences between Alzheimer disease, amnestic mild cognitive impairment and normal aging: diffusion kurtosis. Current Alzheimer research. vol 12. issue 1. 2015-08-28. PMID:25523422. |
examination of hippocampal differences between alzheimer disease, amnestic mild cognitive impairment and normal aging: diffusion kurtosis. |
2015-08-28 |
2023-08-13 |
Not clear |
| Dan Wang, Zhao-Hui Guo, Xing-Han Liu, Yue-Hua Li, He Wan. Examination of hippocampal differences between Alzheimer disease, amnestic mild cognitive impairment and normal aging: diffusion kurtosis. Current Alzheimer research. vol 12. issue 1. 2015-08-28. PMID:25523422. |
to examine hippocampal differences between alzheimer disease (ad), amnestic mild cognitive impairment (amci) and normal aging. |
2015-08-28 |
2023-08-13 |
Not clear |
| E Auning, P Selnes, R Grambaite, J Šaltytė Benth, A Haram, A Løvli Stav, A Bjørnerud, E Hessen, P K Hol, A Muftuler løndalen, T Fladby, D Aarslan. Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment. Acta psychiatrica Scandinavica. vol 131. issue 2. 2015-08-27. PMID:25346330. |
to test the hypothesis that depressive symptoms correlate with alzheimer's disease (ad) type changes in csf and structural and functional imaging including hippocampus volume, cortical thickness, white matter lesions, diffusion tensor imaging (dti), and fluoro-deoxy-glucose positron emission tomography (fdg-pet) in patient with subjective (sci) and mild (mci) cognitive impairment. |
2015-08-27 |
2023-08-13 |
Not clear |
| Katie S Shpanskaya, Kingshuk Roy Choudhury, Christopher Hostage, Kelly R Murphy, Jeffrey R Petrella, P Murali Doraiswam. Educational attainment and hippocampal atrophy in the Alzheimer's disease neuroimaging initiative cohort. Journal of neuroradiology = Journal de neuroradiologie. vol 41. issue 5. 2015-08-25. PMID:24485897. |
educational attainment and hippocampal atrophy in the alzheimer's disease neuroimaging initiative cohort. |
2015-08-25 |
2023-08-12 |
human |
| Roger Delabio, Lucas Rasmussen, Igor Mizumoto, Gustavo-Arruda Viani, Elizabeth Chen, João Villares, Isabela-Bazzo Costa, Gustavo Turecki, Sandra Aparecido Linde, Marilia Cardoso Smith, Spencer-Luiz Payã. PSEN1 and PSEN2 gene expression in Alzheimer's disease brain: a new approach. Journal of Alzheimer's disease : JAD. vol 42. issue 3. 2015-08-25. PMID:24927704. |
150 rna samples from the entorhinal cortex, auditory cortex and hippocampal regions of individuals with alzheimer's disease (ad) and controls elderly subjects were analyzed with using real-time rtpcr. |
2015-08-25 |
2023-08-13 |
human |
| Geidy E Serrano, Marwan N Sabbagh, Lucia I Sue, Jose A Hidalgo, Julie A Schneider, Barry J Bedell, Vivianna M Van Deerlin, Eunran Suh, Haruhiko Akiyama, Abhinay D Joshi, Michael J Pontecorvo, Mark A Mintun, Thomas G Beac. Positive florbetapir PET amyloid imaging in a subject with frequent cortical neuritic plaques and frontotemporal lobar degeneration with TDP43-positive inclusions. Journal of Alzheimer's disease : JAD. vol 42. issue 3. 2015-08-25. PMID:24927705. |
abnormal neuronal accumulation and modification of tar dna binding protein 43 (tdp-43) have recently been discovered to be defining histopathological features of particular subtypes of frontotemporal dementia and amyotrophic lateral sclerosis, and are also common in aging, particularly coexisting with hippocampal sclerosis and alzheimer's disease pathology. |
2015-08-25 |
2023-08-13 |
human |
| Weijie Xu, Yan Yang, Gang Yuan, Wenjun Zhu, Delin Ma, Shuhong H. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. Journal of investigative medicine : the official publication of the American Federation for Clinical Research. vol 63. issue 2. 2015-08-25. PMID:25479064. |
exendin-4, a glucagon-like peptide-1 receptor agonist, reduces alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. |
2015-08-25 |
2023-08-13 |
rat |
| S Tangaro, N Amoroso, M Boccardi, S Bruno, A Chincarini, G Ferraro, G B Frisoni, R Maglietta, A Redolfi, L Rei, A Tateo, R Bellott. Automated voxel-by-voxel tissue classification for hippocampal segmentation: methods and validation. Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB). vol 30. issue 8. 2015-08-24. PMID:25018049. |
the hippocampus is an important structural biomarker for alzheimer's disease (ad) and has a primary role in the pathogenesis of other neurological and psychiatric diseases. |
2015-08-24 |
2023-08-13 |
Not clear |
| Eseosa T Ighodaro, Gregory A Jicha, Frederick A Schmitt, Janna H Neltner, Erin L Abner, Richard J Kryscio, Charles D Smith, Taylor Duplessis, Sonya Anderson, Ela Patel, Adam Bachstetter, Linda J Van Eldik, Peter T Nelso. Hippocampal Sclerosis of Aging Can Be Segmental: Two Cases and Review of the Literature. Journal of neuropathology and experimental neurology. vol 74. issue 7. 2015-08-24. PMID:26083567. |
hippocampal sclerosis of aging (hs-aging) is a neurodegenerative disease that mimics alzheimer disease (ad) clinically and has a prevalence rivaling ad in advanced age. |
2015-08-24 |
2023-08-13 |
human |
| Hilla Fogel, Samuel Frere, Oshik Segev, Shashank Bharill, Ilana Shapira, Neta Gazit, Tiernan O'Malley, Edden Slomowitz, Yevgeny Berdichevsky, Dominic M Walsh, Ehud Y Isacoff, Joel A Hirsch, Inna Slutsk. APP homodimers transduce an amyloid-β-mediated increase in release probability at excitatory synapses. Cell reports. vol 7. issue 5. 2015-08-21. PMID:24835997. |
excessive app activation may initiate a positive feedback loop, contributing to hippocampal hyperactivity in alzheimer's disease. |
2015-08-21 |
2023-08-13 |
Not clear |
| John Provias, Brian Jeyne. Reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in Alzheimer's disease. Current neurovascular research. vol 11. issue 3. 2015-08-21. PMID:24845858. |
reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in alzheimer's disease. |
2015-08-21 |
2023-08-13 |
Not clear |
| John Provias, Brian Jeyne. Reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in Alzheimer's disease. Current neurovascular research. vol 11. issue 3. 2015-08-21. PMID:24845858. |
fifteen alzheimer (ad) and fifteen normative (nm) age-matched autopsy brains were analyzed in superior temporal cortex, hippocampal and brainstem samples. |
2015-08-21 |
2023-08-13 |
Not clear |
| John Provias, Brian Jeyne. Reduction in vascular endothelial growth factor expression in the superior temporal, hippocampal, and brainstem regions in Alzheimer's disease. Current neurovascular research. vol 11. issue 3. 2015-08-21. PMID:24845858. |
within alzheimer's superior temporal, hippocampus and brainstem sites there was reduced vegf expression, with the p value being less than 0.05 in all three sites (superior temporal less than 0.035, hippocampus less than 0.001, brainstem less than 0.006). |
2015-08-21 |
2023-08-13 |
Not clear |